Found: 33
Select item for more details and to access through your institution.
Clinical Significance of Cartilage Biomarkers for Monitoring Structural Joint Damage in Rheumatoid Arthritis Patients Treated with Anti-TNF Therapy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0037447
- By:
- Publication type:
- Article
Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 3, p. 1, doi. 10.1093/rap/rkac090
- By:
- Publication type:
- Article
Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with corticosteroids and literature review.
- Published in:
- Clinical Rheumatology, 2017, v. 36, n. 10, p. 2383, doi. 10.1007/s10067-017-3752-0
- By:
- Publication type:
- Article
Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review.
- Published in:
- Clinical Rheumatology, 2012, v. 31, n. 3, p. 569, doi. 10.1007/s10067-011-1917-9
- By:
- Publication type:
- Article
Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis.
- Published in:
- Arthritis Care & Research, 2012, v. 64, n. 8, p. 1125, doi. 10.1002/acr.21666
- By:
- Publication type:
- Article
Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13075-015-0583-8
- By:
- Publication type:
- Article
Discontinuation of tofacitinib after achieving low disease activity in patients with rheumatoid arthritis: a multicentre, observational study.
- Published in:
- Rheumatology, 2017, v. 56, n. 8, p. 1293, doi. 10.1093/rheumatology/kex068
- By:
- Publication type:
- Article
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients—REACTION 52-week study.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients—REACTION 52-week study.
- Published in:
- Rheumatology, 2011, v. 50, n. 10, p. 1908, doi. 10.1093/rheumatology/ker221
- By:
- Publication type:
- Article
IgG4-positive multi-organ lymphoproliferative syndrome manifesting as chronic symmetrical sclerosing dacryo-sialadenitis with subsequent secondary portal hypertension and remarkable IgG4-linked IL-4 elevation.
- Published in:
- Rheumatology, 2010, v. 49, n. 9, p. 1789, doi. 10.1093/rheumatology/keq113
- By:
- Publication type:
- Article
Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study.
- Published in:
- Modern Rheumatology, 2020, v. 30, n. 3, p. 442, doi. 10.1080/14397595.2019.1621026
- By:
- Publication type:
- Article
Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 4, p. 609, doi. 10.3109/14397595.2014.980384
- By:
- Publication type:
- Article
Efficacy and safety of abatacept in routine care of patients with rheumatoid arthritis: Orencia<sup>®</sup> as Biological Intensive Treatment for RA (ORBIT) study.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 5, p. 754, doi. 10.3109/14397595.2013.872862
- By:
- Publication type:
- Article
A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and Japan.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 4, p. 572, doi. 10.3109/14397595.2013.860695
- By:
- Publication type:
- Article
Addition of another disease-modifying anti-rheumatic drug to methotrexate reduces the flare rate within 2 years after infliximab discontinuation in patients with rheumatoid arthritis: An open, randomized, controlled trial.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 4, p. 561, doi. 10.3109/14397595.2013.844886
- By:
- Publication type:
- Article
Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 3, p. 399, doi. 10.3109/14397595.2013.843757
- By:
- Publication type:
- Article
Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs.
- Published in:
- Modern Rheumatology, 2013, v. 23, n. 2, p. 284, doi. 10.3109/s10165-012-0657-2
- By:
- Publication type:
- Article
A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology.
- Published in:
- Modern Rheumatology, 2013, v. 23, n. 2, p. 297, doi. 10.3109/s10165-012-0658-1
- By:
- Publication type:
- Article
Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis.
- Published in:
- Modern Rheumatology, 2013, v. 23, n. 1, p. 97, doi. 10.3109/s10165-012-0645-6
- By:
- Publication type:
- Article
Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors.
- Published in:
- Modern Rheumatology, 2012, v. 22, n. 6, p. 849, doi. 10.3109/s10165-012-0615-z
- By:
- Publication type:
- Article
Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study).
- Published in:
- Modern Rheumatology, 2012, v. 22, n. 3, p. 327, doi. 10.3109/s10165-011-0516-6
- By:
- Publication type:
- Article
Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept.
- Published in:
- Modern Rheumatology, 2012, v. 22, n. 2, p. 186, doi. 10.3109/s10165-011-0510-z
- By:
- Publication type:
- Article
Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis.
- Published in:
- Modern Rheumatology, 2010, v. 20, n. 4, p. 337, doi. 10.3109/s10165-010-0284-8
- By:
- Publication type:
- Article
Improvement of the HAQ score by infliximab treatment in patients with RA: its association with disease activity and joint destruction.
- Published in:
- Modern Rheumatology, 2009, v. 19, n. 2, p. 166, doi. 10.3109/s10165-008-0142-0
- By:
- Publication type:
- Article
Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J).
- Published in:
- Modern Rheumatology, 2008, v. 18, n. 5, p. 447, doi. 10.3109/s10165-008-0077-5
- By:
- Publication type:
- Article
Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis.
- Published in:
- Modern Rheumatology, 2007, v. 17, n. 2, p. 92, doi. 10.3109/s10165-006-0545-8
- By:
- Publication type:
- Article
Development and validation of handy rheumatoid activity score with 38 joints (HRAS38) in rheumatoid arthritis patients receiving infliximab.
- Published in:
- Modern Rheumatology, 2006, v. 16, n. 6, p. 381, doi. 10.3109/s10165-006-0528-9
- By:
- Publication type:
- Article
Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis: a better response in male patients.
- Published in:
- Modern Rheumatology, 2004, v. 14, n. 6, p. 442, doi. 10.3109/s10165-004-0340-3
- By:
- Publication type:
- Article
The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database.
- Published in:
- Rheumatology International, 2014, v. 34, n. 12, p. 1729, doi. 10.1007/s00296-014-3045-8
- By:
- Publication type:
- Article
Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus.
- Published in:
- Rheumatology International, 2011, v. 31, n. 6, p. 757, doi. 10.1007/s00296-010-1366-9
- By:
- Publication type:
- Article
Single center prospective study of tacrolimus efficacy and safety in treatment of rheumatoid arthritis.
- Published in:
- Rheumatology International, 2009, v. 29, n. 4, p. 431, doi. 10.1007/s00296-008-0833-z
- By:
- Publication type:
- Article
Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02612-w
- By:
- Publication type:
- Article